The Prime Minister’s Clarion Call on Antimicrobial Resistance: From Public Concern to System Action through Diagnostics, Stewardship and One Health
DOI:
https://doi.org/10.56450/JEFI.2025.v3i04.008Keywords:
Antimicrobial Resistance, Stewardship, One Health, Point-Of-Care Diagnostics, India, Primary CareAbstract
Antimicrobial resistance (AMR) is a major and growing threat to health security. It weakens the treatment of common infections and undermines the safety of routine medical care. In his Mann Ki Baat message of 28 December 2025, the Prime Minister warned that indiscriminate antibiotic use is making common infections such as pneumonia and urinary tract infections harder to treat, and urged citizens not to use antibiotics as a ‘quick fix’. This commentary takes that clarion call as a starting point. It proposes three practical system shifts for India: (i) diagnostic-led stewardship at the point of care, (ii) routine monitoring of antibiotic use and resistance with feedback to facilities, and (iii) operational One Health action at priority human–animal–environment interfaces. The goal is to make the right antibiotic decision the easy decision
Downloads
References
1. World Health Organization. Antimicrobial resistance: Fact sheet. WHO; 2023 (updated).
2. Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.
3. Ministry of Health and Family Welfare, Government of India. News highlights: PM cites ICMR report in Mann Ki Baat and warns against indiscriminate use of antibiotics driving AMR. MoHFW website; 2025.
4. United Nations. Political Declaration of the High-level Meeting on Antimicrobial Resistance (final text). UN; 2024.
5. United Nations. General Assembly adopts Political Declaration on AMR; includes target to reduce deaths associated with bacterial AMR by 10% by 2030. UN Press Release; 2024.
6. World Health Organization. World leaders commit to decisive action on antimicrobial resistance, including target to reduce human deaths from AMR by 10% by 2030. WHO News Release; 2024.
7. Press Information Bureau, Government of India. Union Health Minister launches National Action Plan on Antimicrobial Resistance 2.0 (2025–29). PIB; 18 Nov 2025.
8. National Centre for Disease Control (NCDC), MoHFW. National Action Plan on Antimicrobial Resistance 2.0 (2025–2029). NCDC; 2025.
9. Martínez-González NA, Keizer E, Plate A, et al. Point-of-care C-reactive protein testing to reduce antibiotic prescribing for respiratory tract infections in primary care: systematic review and meta-analysis. Antibiotics (Basel). 2020;9(9):610.
10. Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017;2:CD003543.
11. Indian Council of Medical Research. Treatment Guidelines for Antimicrobial Use in Common Syndromes (2nd ed.). New Delhi: ICMR; 2019.
12. Indian Council of Medical Research. National Essential Diagnostics List (NEDL). New Delhi: ICMR; 2019.
13. Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA. 2018;115:E3463–70.
14. National Centre for Disease Control (NCDC), MoHFW. National Programme on AMR Containment (overview page). NCDC; accessed 2026.
15. National Centre for Disease Control (NCDC), MoHFW. National AMR Surveillance Network (NARS-Net) Annual Report 2023. NCDC; 2024.
16. Indian Council of Medical Research. Antimicrobial Resistance Surveillance Network (AMRSN) Annual Report 2024. ICMR; 2025.
17. National Centre for Disease Control (NCDC), MoHFW. National Antibiotic Consumption Network (NAC-NET) Report 2022. NCDC; 2025.
18. Ministry of Health and Family Welfare, Government of India. Ayushman Bharat Health and Wellness Centres: Reforms Booklet (updated). MoHFW; 2021.
19. National Health Systems Resource Centre (NHSRC)/NHM. Operational Guidelines: Free Diagnostics Services Initiative (FDSI). NHSRC/NHM; 2025.
20. Central Drugs Standard Control Organisation (CDSCO). Inclusion of Schedule H1 (notification document). CDSCO; 2013/2014.
21. Hazra A. Schedule H1: Hope or hype? Indian J Pharmacol. 2014;46:361–2.
22. Press Information Bureau, Government of India. Update on overuse of antimicrobials: Red Line awareness campaign and initiatives to promote judicious use. PIB; 10 Feb 2023.
23. Ministry of Health and Family Welfare/NCDC. National Guidelines for Infection Prevention and Control in Healthcare Facilities. MoHFW; 2020.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 K Madan Gopal, Suneela Garg (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
